Lisata Therapeutics Inc. (LSTA) — Cash Flow Quality Index

Latest as of June 2020: 0.68x

Lisata Therapeutics Inc. (LSTA) has a Cash Flow Quality Index of 0.68x as of June 2020. Operating cash flow of $4.50 Million is below net income of $6.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore LSTA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

0.68x
Operating CF / Net Income

Operating Cash Flow

$4.50 Million
USD

Net Income

$6.60 Million
USD

Data as of

Jun 2020
Most recent filing

Lisata Therapeutics Inc. Cash Flow Quality Index (1995–1995)

Historical Cash Flow Quality Index for Lisata Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LSTA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Lisata Therapeutics Inc. (1995–1995)

Year-by-year earnings quality comparison for Lisata Therapeutics Inc.. For live market cap and the full company financial profile, see market cap of Lisata Therapeutics Inc..

Year Quality Index Operating CF (USD) Net Income YoY Change
1995 -275.62x $-838.44K $3.04K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.